MIRA INFORM REPORT

 

 

Report Date :

18.04.2012

 

IDENTIFICATION DETAILS

 

Name :

FERMENTA BIOTECH LIMITED (w.e.f. 10.05.2000)

 

 

Formerly Known As :

FERMENTAPHARMA BIODIL LIMITED

 

 

Registered Office :

DIL Complex, Ghodbunder Road, Majiwada, Thane(W)-400 610, Thane Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

11.07.1986

 

 

Com. Reg. No.:

11-134021

 

 

Capital Investment / Paid-up Capital :

Rs.177.045 Millions

 

 

CIN No.:

[Company Identification No.]

U99999MH1986PLC134021

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturing of Formulations, Drug, Intermediates and Biocatalyst

 

 

No. of Employees :

500 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 2300000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct 

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well – established and a reputed company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 

 

 

 

 

 

 

 

 

 


 

INFORMATION PARTED BY

 

Name :

Mr. Dilip

Designation :

Manager

Contact No.:

91-9930128326 (Mr. Dilip)

Date :

10.04.2012

 

 

LOCATIONS

 

Registered Office:

DIL Complex, Ghodbunder Road, Majiwada, Thane (West) -400 610, Maharashtra, India

Tel. No.:

91-22-67980888

Mobile No.:

91-9930128326 (Mr. Dilip)

Fax No.:

91-22-67980999/67980899?

E-Mail :

Dilip.peswani@fermentabiotech.com

fermenta@fermentabiotech.com

Website :

www.fermentabiotech.com

Location:

Owned

 

 

Factory 1 :

Village Takoli, P. O. Nagwain, District Mandi, Himachal Pradesh – 175 121, India

Tel. No.:

91-1905-287246

Fax No.:

91-1905-287250

E-mail:

fblmandi@fermentabiotech.com

 

 

Factory 2 :

Dahej, Gujarat

 

 

DIRECTORS

As on 27.09.2011

 

Name :

Mr. Satish Varma Azad Nadimpally

Designation :

Director

Address :

Flat No. 1104, Quiscent Heights, Mindspace Link Road, Malad(W), Mumbai - 400 064, Maharashtra, India

Qualification:

Computer Science

Date of Birth/Age :

21.03.1970

Date of Appointment :

04.10.2004

DIN :

00003255

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

L99999MH1951PLC008485

DIL LIMITED

Director

30-04-10

01-07-03

-

Active

NO

2

U67120MH2003PTC141695

DVK INVESTMENTS PRIVATE LIMITED

Director

11-08-03

11-08-03

-

Active

NO

3

U45200MH1995PLC084766

AEGEAN PROPERTIES LIMITED

Director

01-09-03

01-09-03

-

Active

NO

4

U74130MH2004PTC145141

EVOTEC (INDIA) PRIVATE LIMITED

Director

17-03-04

17-03-04

31-08-09

Active

NO

5

U92100MH2004PLC145627

WHITE STRIPES ENTERTAINMENT LIMITED

Director

12-04-04

12-04-04

-

Amalgamated

NO

6

U24230MH2004PTC148220

G I BIOTECH PRIVATE LIMITED

Director

25-08-04

25-08-04

-

Active

NO

7

U99999MH1986PLC134021

FERMENTA BIOTECH LIMITED

Managing director

01-05-10

04-10-04

-

Active

NO

8

U55101MH2005PTC152711

VM CAFE DE ART PRIVATE LIMITED

Director

02-08-05

02-08-05

-

Active

NO

9

U93000MH2011PLC212089

CC Square Films Limited

Director

10-01-11

10-01-11

-

Active

NO

 

 

Name :

Mr. Krishna Vasant Datla

Designation :

Director

Address :

42 – B, Dhanaajay JVPD Presidency CHS., 8 North South Road, Juhu, Mumbai 400 049, Maharashtra, India

Date of Birth/Age :

17.12.1980

Date of Appointment :

01.02.2002

DIN :

00003247

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U99999MH1986PLC134021

FERMENTA BIOTECH LIMITED

Director

01-02-02

01-02-02

-

Active

NO

2

L99999MH1951PLC008485

DIL LIMITED

Managing director

09-05-10

29-01-05

-

Active

NO

3

U55101MH2005PTC152711

VM CAFE DE ART PRIVATE LIMITED

Director

02-05-05

02-05-05

-

Active

NO

4

U74130MH2004PTC145141

EVOTEC (INDIA) PRIVATE LIMITED

Director

09-05-05

09-05-05

05-10-11

Active

NO

5

U45200MH1995PLC084766

AEGEAN PROPERTIES LIMITED

Director

09-05-05

09-05-05

-

Active

NO

6

U67120MH2003PTC141695

DVK INVESTMENTS PRIVATE LIMITED

Director

09-05-05

09-05-05

-

Active

NO

7

U24230MH2004PTC148220

G I BIOTECH PRIVATE LIMITED

Director

27-10-05

27-10-05

-

Active

NO

8

U92100MH2004PLC145627

WHITE STRIPES ENTERTAINMENT LIMITED

Director

01-02-06

01-02-06

-

Amalgamated

NO

9

U85100MH2007FLC175165

Evotec-RSIL Limited

Director

18-10-07

18-10-07

-

Amalgamated

NO

10

U85100KA2008PTC047190

Health and Wellness India Private Limited

Additional director

13-12-10

13-12-10

28-03-11

Active

NO

11

U93000MH2011PLC212089

CC Square Films Limited

Director

10-01-11

10-01-11

-

Active

NO

12

U55204MH2011PTC222081

Magnolia FNB Private Limited

Director

16-09-11

16-09-11

-

Active

NO

 

 

Name :

Mr. Sanjay Ramakant Buch

Designation :

Director

Address :

31/7, Sona CHS., K.C.Marg, Bandra Reclamations, Bandra (West), Mumbai – 400050, Maharashtra, India

Date of Birth/Age :

26.09.1968

Date of Appointment :

22.01.2010

DIN :

00391436

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24246AP1989PTC010416

SS ORAL HYGIENE PRODUCTS PRIVATE LIMITED

Director

03-12-99

03-12-99

-

Amalgamated

NO

2

L99999MH1951PLC008485

DIL LIMITED

Director

14-09-07

28-04-07

-

Active

NO

3

U99999MH1993PTC074256

AGFA INDIA PRIVATE LIMITED

Director

27-11-08

07-04-08

18-01-10

Amalgamated

NO

4

U72900MH2008FTC186575

Emhart Teknologies (India) Private Limited

Director

09-09-08

09-09-08

16-09-10

Active

NO

5

U31409KA2008FTC047837

Black & Decker India Private Limited

Director

23-09-08

23-09-08

18-01-10

Active

NO

6

U24110MH1993PLC070713

INDOFIL INDUSTRIES LIMITED

Director appointed in casual vacancy

11-08-09

11-08-09

-

Active

NO

7

U63090MH1983PTC161369

TRANSWAYS COMBINES PRIVATE LIMITED (TRF.)

Additional director

29-08-09

29-08-09

30-09-09

Active

NO

8

U99999MH1986PLC134021

FERMENTA BIOTECH LIMITED

Director

27-09-10

22-01-10

-

Active

NO

9

U93000MH2010FTC211208

SEALCOM INDIA PRIVATE LIMITED

Director

22-12-10

22-12-10

-

Active

NO

 

 

Name :

Mr. Rajendra Balkrishna Gajtonde

Designation :

Whole Time Director

Address :

505  Santoor Society, Lokpuram, Thane (West) - 400 610, Maharashtra, India

Date of Birth/Age :

01.06.1962

Date of Appointment :

04.10.2004

DIN :

00003269

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U99999MH1986PLC134021

FERMENTA BIOTECH LIMITED

Whole-time director

04-10-10

04-10-04

-

Active

NO

 

 

Name :

Mrs. Anupama Vasantkumar Datla

Designation :

Whole Time Director

Address :

A/802, Aditya Samarth, Ramdas Marg, Juhu Scheme, Mumbai – 400049,  Maharashtra, India

Date of Birth/Age :

12.06.1978

Qualification :

Post Graduate in Biotechnology

Science Graduate from The Boston College

Date of Appointment :

29.03.2007

DIN :

00217027

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U99999MH1996PTC103910

LACTO COSMETICS (VAPI) PRIVATE LIMITED

Director

01-11-03

01-11-03

-

Active

NO

2

U24239MH1976PTC103955

DUPEN LABORATORIES PRIVATE LIMITED

Director

15-12-04

15-12-04

-

Active

NO

3

U99999MH1986PLC134021

FERMENTA BIOTECH LIMITED

Whole-time director

01-04-12

29-03-07

-

Active

NO

 

 

Name :

Mr. Peter John Bains

Designation :

Chairman

Address :

Hutchins Barn, Forty Green Road, Knotty Green, HP9IXL, Beaconsfield, United Kingdom - 76152

Date of Birth/Age :

26.07.1957

Date of Appointment :

19.03.2010

DIN :

00430937

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

L24239MH1924PLC001151

GLAXOSMITHKLINE PHARMACEUTICALS LIMITED

Director

26-07-05

26-07-05

27-07-09

Active

NO

2

U51909KA1993PLC014937

SYNGENE INTERNATIONAL LIMITED

Director

22-07-10

20-01-10

-

Active

NO

3

U99999MH1986PLC134021

FERMENTA BIOTECH LIMITED

Director

27-09-10

19-03-10

-

Active

NO

 

 

Name :

Mr. Viswanath Venkata Subrahmanya anjaneya Chibrolu

Designation :

Director

Address :

Flat No. 302, Chaitanya Estates, Moti Nagar, X Road, Hyderabad – 500018, Andhra Pradesh, India

Date of Birth/Age :

12.08.1969

Date of Appointment :

17.01.2011

DIN :

01556254

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U74140AP2006PTC050912

INVASCENT ADVISORY SERVICES INDIA PRIVATE LIMITED

Director

13-07-07

13-07-07

-

Active

NO

2

U24236KA1995PTC019479

EASYSTICH NEEDLES PRIVATE LIMITED

Additional director

24-08-09

24-08-09

-

Amalgamated

NO

3

U03311KA1992PTC013831

SUTURES INDIA PRIVATE LIMITED

Director

25-08-10

26-08-09

-

Active

NO

4

U99999MH1986PLC134021

FERMENTA BIOTECH LIMITED

Director

17-01-11

17-01-11

-

Active

NO

 

 

Name :

Mr. Tiruneveli Padmanabhan Devarajan

Designation :

Director

Address :

10.03.152 (New No 38 ST No 2) East, Marredpally, Secunderabad – 500026, Andhra Pradesh, India

Date of Birth/Age :

28.03.1964

Date of Appointment :

14.03.2001

DIN :

03473633

 

KEY EXECUTIVES

 

Name :

Mr. Ranabir Sanyal

Designation :

Secretary

Address :

B-605, Laxmi Narayan Complex, Sector 12A, Koparkhairane, Navi Mumbai – 400709, India

Date of Birth/Age :

25.09.1984

Date of Appointment :

01.10.2009

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

As on 27.09.2011

 

Names of Shareholders

 

No. of Shares

Dr. V. K. Datla

 

12

Mr. D. G. Rajan

 

12

Mr. O. Swaminatha Reddy

 

12

DIL Limited, Thane

 

12762464

V. R. Investment and Finance Private Limited, Hyderabad

 

15000

Mrs. D. Rajeshwari

 

85338

Mr. Govind Desai and Mr. Gunanath Govind Desai

 

2500

Mr. Govind Desai and Mr. Damodar Govind Desai

 

1000

Mrs. Shaila G. Desai and Mr. Damodar Govind Desai

 

1500

Mr. S. Krishnan

 

10

Mr. S C Uniyal

 

10

Ms. Preeti Thakkar

 

3012

Dupen Laboratories P Limited, Santacruz

 

100000

Mr. Kumar Subrmanian

 

10

Mr. S Raman

 

10

Mr. Prashant Kutty

 

20

DVK Investments Private Limited,Thane

 

87024

Mr. K H Kashid

 

10

Mr. Krishna Datla Jtly Mr. Rajeshwari Datla

 

27000

Mr. Satish Varma

 

10

Mr. Irfan Bandukwala

 

789474

Allegro Corporate Financial Advisors Private Limited

 

488334

Mr. Srikant Sharma

 

10

Evolvence India Life Science Fund LLC

 

3830072

 

 

 

Total

 

18192844

 

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

21.05

Bodies corporate

78.29

Directors or relatives of Directors

0.63

Other top fifty shareholders

0.03

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing of Formulations, Drug, Intermediates and Biocatalyst

 

 

Products :

ITC Code

Product Description

30029000

Plnicillin G Amidas Biocaialysi

293331

Phenyramidol HCL

293629.13

Vitamin D3

 

 

.Exports :

 

Products :

Formulations, Drug, Intermediates and Biocatalyst

Countries :

North America, Middle East, South America, Korea, South east Asia

 

 

Imports :

 

Products :

Raw Material

Countries :

Europe

 

 

Terms :

 

Selling :

L/C Cash and Credit

 

 

Purchasing :

L/C Cash and Credit

 

PRODUCTION STATUS (31.03.2011)

 

Particulars

Unit

 

Installed Capacity

Actual Production

Biocatalyst and enzymes

Kgs

 

7000

25,429

Formulations tablets and lozenges

Blister Packs ‘000’

 

----

1,493

Bulk Drugs

Kgs

 

101,900

129,410

 

 

 

 

 

 

Note: (a) Licensed capacity is not indicated as industrial licensing for all bulk drugs, intermediate and their formulations stands abolished in terms of Press Note No.4 (1994 Series) dated 25th October, 1994 issued by the Department of Industrial Development, Ministry of Industry, and Government of India.

 

 (b) * Installed capacity (201 0-201 1 and 2009-2010) has been certified by the Vice President Manufacturing and accepted by the auditors without verification, this being a technical matter. .

 

(c) ** Closing stock quantities exclude stocks written off (i) ~iocatalis-t 442 Kgs (2010 - 795 Kgs), and (ii) Bulk Drugs - 3170 Kgs (2010 - 120 Kgs).

 

(d) *** Sales quantity includes: Free supllies of (i) 3,170Kgs of Bulk Drug (2010 - 2,253 Kgs); and (ii) 25 Kgs of Biocatalyst (2010 - 60 Kgs)

 

(e) ****Production includes quantity manufactured by loan licensee. Biocatalyst and Enzymes - 21445 Kgs (2010 - 8200 Kgs),

Formulations Tablets and Lozenges - 1493 Blister Packs '000 (2010 - Nil) Bulk Drug - 47550 Kgs (2010 - Nil)

 

20 Prior year amounts have been reclassified where necessary to confirm with current year's presentation.

 

GENERAL INFORMATION

 

Customers :

·       Wholesalers and Retailers

·       Supreme Dharma cauticals Private Limited Customers

 

 

No. of Employees :

500 (Approximately)

 

 

Bankers :

Union Bank Of India, Ghodbunder Road Branch, Solitaire Tower,  Manpada, Ghodbunder Road, Thane – 400607, Maharashtra, India

 

 

(Rs. In Millions)

Facilities :

Secured Loan

As on

31.03.2011

 

As on

31.03.2010

 

 

Secured loans

 

 

(A) Working capital loans banks secured

15.594

29.934

(B) Loans taken for vehicles secured

6.634

2.919

(C) Loans taken for other fixed assets secured

121.106

59.967

(D) Other debt secured

40.000

40.000

Total

183.334

132.820

 

 

 

Note: (A) Cash Credit Secured by way of hypothecation of the Company's entire stocks of raw materials, semi-finished and finished goods, consumable stores and spares and such other moveable including book-debts, bills, whether documentary or clean, outstanding monies, receivables, and also by way of first charge on all of the Company's fixed assets both present and future.

 

(B) (Repayable within a year Rs.2.419 Millions (2010-Rs.1.776 Millions)

 

(C) Secured by way of first charge on fixed assets procured with financial assistance of the term loan and by equitable mortgage of factory land and building at Kullu. (Repayable within a year Rs.24.023 Millions (2010-Rs.21.282 Millions), The following amount has been obtained by adding two components. 1)Secured by way of first charge on fixed assets procured with financial assistance of the term loan and by equitable mortgage of factory land and building at Kullu. (Repayable within a year Rs.24.023 Millions (2010-Rs.21.282 Millions).Current Year amount is 47.206 Millions (P.Y-59.967 Millions) 2)Secured by way of first charge on fixed assets procured with financial assistance of the term loan and by equitable

Mortgage of factory land and building at Dahej pending execution. (Repayable within a year Rs.12.500 Millions (2010-Rs.NIL).Current Year figure is 7.900 Millions and is NIL for the previous year.

 

(D) Packing Credit Secured by way of hypothecation of the Company's entire stocks of raw materials, semi-finished, and finished goods, consumable stores and spares and such other moveable including book-debts, bills, whether documentary or clean, outstanding monies, receivables, and also by way of first charge on all of the Company's fixed assets both present and future.

 

 

 

Secured Loan

As on

31.03.2011

 

As on

31.03.2010

 

 

Unsecured loans [abstract]

 

 

 (A) Other debt unsecured

15.987

30.000

Total

15.987

30.000

 

 

 

Note:  (A) Short term loan from Holding company (includes interest accrued Rs.2.360 Millions (2010-Rs.NIL)

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S.R. Batliboi and Associates

Chartered Accountant

Address :

14th Floor, The Ruby, 29 Senapati Bapat Marg, Dadar (West), Mumbai – 400028, Maharashtra, India

PAN.:

AABFS3421N

 

 

Associates/Subsidiaries :

G I Biotech Private Limited, India

U24230MH2004PTC148220

 

 

Fellow Subsidiary Company:

Evotec (India) Private Limited, India

 

 

CAPITAL STRUCTURE

As on 27.09.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

19010000

Equity Shares

Rs.10/- each

Rs.190.100 Millions

 

 

 

 

990000

Preference Shares

Rs.10/- each

Rs.9.900 Millions

 

 

 

 

Total

 

 

Rs. 200.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

18192844

Equity Shares

Rs.10/- each

Rs. 181.928 Millions

 

 

 

 

 

 

 

 

 

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

19010000

Equity Shares

Rs.10/- each

Rs.190.100 Millions

 

 

 

 

990000

Preference Shares

Rs.10/- each

Rs.9.900 Millions

 

 

 

 

Total

 

 

Rs. 200.000 Millions

 

 

Issued, Subscribed

No. of Shares

Type

Value

Amount

 

 

 

 

18192844

Equity Shares

Rs.10/- each

Rs. 181.928 Millions

 

 

 

 

 

 

 

 

 

Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

17704510

Equity Shares

Rs.10/- each

Rs. 177.045 Millions

 

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

177.045

87.000

87.000

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

410.033

207.932

166.059

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

587.078

294.932

253.059

LOAN FUNDS

 

 

 

1] Secured Loans

183.334

132.820

142.457

2] Unsecured Loans

15.987

30.000

0.000

TOTAL BORROWING

199.321

162.820

142.457

DEFERRED TAX LIABILITIES

0.882

0.000

0.000

 

 

 

 

TOTAL

787.281

457.752

395.516

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

288.244

208.866

192.504

Capital work-in-progress

185.000

56.850

7.696

 

 

 

 

INVESTMENT

18.662

18.662

18.662

DEFERREX TAX ASSETS

0.000

3.275

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

104.537
71.463
74.654

 

Sundry Debtors

155.922
112.367
108.523

 

Cash & Bank Balances

103.819
31.928
26.022

 

Other Current Assets

0.000
0.000
0.000

 

Loans & Advances

38.950
26.697
34.029

Total Current Assets

403.228

242.455

243.228

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

77.562
38.394
34.599

 

Other Current Liabilities

5.903
19.672
21.578

 

Provisions

24.388
14.290
10.397

Total Current Liabilities

107.853

72.356

66.574

Net Current Assets

295.375
170.099
176.654

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

787.281

457.752

395.516

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

642.947

480.157

351.080

 

 

Other Income

12.795

2.987

19.971

 

 

TOTAL                                     (A)

655.742

483.144

371.051

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Purchase of Trading Goods

9.367

0.000

 

 

Material Consumed

 

134.266

89.818

 

 

Increase/Decrease in inventories

 

(1.916)

16.952

 

 

Manufacturing Expenses

 

63.197

51.676

 

 

Personnel Expenses

 

68.511

58.624

 

 

Selling and Distribution Expenses

 

37.002

27.615

 

 

Administration and other expenses

 

87.691

74.510

 

 

TOTAL                                     (B)

217.885

398.118

319.195

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

437.857

85.026

51.856

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

17.095

14.412

15.765

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

420.762

70.614

36.091

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

297.199

23.125

17.062

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

123.563

47.489

19.029

 

 

 

 

 

Less

TAX                                                                  (I)

29.108

5.616

2.942

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

94.455

41.873

16.087

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

132.362

90.489

74.402

 

 

 

 

 

Less

TRANSFERRED TO CAPITAL REDEMPTION RESERVE

7.000

0.000

0.000

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

219.817

132.362

90.489

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB Value of Export

341.423

224.761

 

 

Freight and insurance on exports

 

7.519

6.199

 

 

Other Earnings

 

0.000

7.060

 

TOTAL EARNINGS

NA

348.942

238.02

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

57.359

40.817

 

 

Stores & Spares

 

0.000

0.048

 

 

Capital Goods

NA

5.165

3.435

 

TOTAL IMPORTS

 

62.524

44.300

 

 

 

 

 

 

Earnings Per Share (Rs.)

5.19

5.23

2.01

 

Sales Turnover (2011-2012) : Rs. 1000.000 Millions (Due to More Orders and Increase Facility )

 

Expected Sales (2012-2013 ) : Rs. 1250.000 Millions

 

The above information has been parted by Mr. Dilip - Manager

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

14.40

8.67

4.19

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

19.21

9.89

5.23

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

30.64

10.52

4.12

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.21

0.16

0.08

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.18

0.80

0.83

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

3.73

3.35

3.65

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes

4) Premises details

No

5) Type of Business

Yes

6) Line of Business•

Yes

7) Promoter’s background

Yes

8) No. of employees

Yes

9) Name of person contacted

Yes

10) Designation of contact person

Yes

11) Turnover of firm for last three years

Yes

12) Profitability for last three years

Yes

13) Reasons for variation <> 20%

Yes

14) Estimation for coming financial year

Yes

15) Capital in the business

Yes

16) Details of sister concerns

Yes

17) Major suppliers

No

18) Major customers

Yes

19) Payments terms

Yes

20) Export / Import details (if applicable)

Yes

21) Market information

--

22) Litigations that the firm / promoter

--

23) Banking Details

Yes

24) Banking facility details

Yes

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

Yes

28) Incorporation details, if applicable

Yes

29) Last accounts filed at ROC

Yes

30) Major Shareholders, if available

Yes

 

RESULT FROM OPERATIONS

 

In 2010-11, the revenue generated stood at Rs. 655.742 Millions as against Rs. 483.144 Millions in the previous year. Profit before tax was Rs.123.563 Millions (previous year Rs.47.489 Millions) and the profit after tax was Rs. 94.455 Millions (Previous year Rs. 41.873 Millions)

 

Trade Reference:-

·       Supreme Dharma cauticals Private Limited Customers

 

Corporate identity number of the company

U99999MH1986PLC134021

Name of the company

FERMENTA BIOTECH LIMITED

Address of the registered office or of the principal place of  business in India of the company

DIL Complex, Ghodbunder Road, Majiwada, Thane(W)-400 610, Maharashtra, India

 

Email: fermenta@fermentabiotech.com

This form is for

Creation of charge

Type of charge

·         Movable property

·         Any interest in immovable property

Particular of charge holder

Union Bank Of India, Solitier Tower, Manpada, Ghodbunder Road, Thane-400610, Maharashtra, India

E-mail: cbsghodbunderroad@unionbankofindia.com

Nature of instrument creating charge

Simple Mortgage Deed

Date of instrument Creating the charge

19.5.2011

Amount secured by the charge

Rs.324.909 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

As determined by the Bank from time to time

 

Terms of Repayment

Term Loan in installments and other facilities on Demand

 

Margin

As per sanction terms

 

Extent and Operation of the charge

To Secure Various  facilties aggregating to Rs.324.909 Millions granted by the Bank to the Company as under :- Amount (Rs. in Lacs)

 

1. CC Hyp Stocks & Book-Debts  Rs.30.000 Millions

2.PCFC limit Agst confirmed orders/LC Rs.20.000 Millions

3.FDBP/FUDBP Rs.20.000 Millions

4. Term Loan I Rs14.870 Millions

5. Term Loan II Rs. 8.963 Millions 6.Term Loan III Rs.14.869 Millions 7.Term Loan IV Rs.15.860 Millions 8. Term Loan V Rs.200.000 Millions 9. Union Miles Rs 0.347 Millions

Total Aggregating Rs.324.909 Millions

 

Short particulars of the property or asset(s) charged (including complete address and location of the property)

·         The Mortgagor as Sole Sublease holders hereby transfers to the Mortgagee by way of Registered Mortgage All that piece and parcel of land known as Plot No. Z/109/B & Z/109/C in Dahej SEZ (cont)

 

·         consisting of Revenue Survey Nos 476/P,477/P,478/P,479/P,504/P,505/P,506/P,507/P & 508/P within the Village limits of Lakhigam,Taluka Vagra District Bharuch containing by admeasurements (cont)

 

·         30689.39 Sq.Mtrs (tentative) or thereabout and bounded as follows that is to say:

·         On or towards North: Plot No. Z/109/A

·         On or towards South : 10 MT wide road

·         On or towards East : Plot Z/109 (cont)

 

·         On or towards West: 10MT wide Corridor & 30 mt wide road

 

Fixed Assets:-

 

·         Freehold Land

·         Building

·         Plant and Machinery

·         Office Equipment

·         Furniture and Fixture

·         Vehicles

·         Software

·         Product Know-how

 

 

·       c

 

 

 

 

 

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.51.65

UK Pound

1

Rs.81.79

Euro

1

Rs.67.18

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

---

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

Yes

--LITIGATION

YES/NO

No

--OTHER ADVERSE INFORMATION

YES/NO

No

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

No

--EXPORT ACTIVITIES

YES/NO

Yes

--AFFILIATION

YES/NO

Yes

--LISTED

YES/NO

No

--OTHER MERIT FACTORS

YES/NO

Yes

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.